DOI: 10.12890/2025_005699

Supraventricular tachycardia in a young adult with congenital heart disease: successful ablation after patent ductus arteriosus closure

Authors

  • Bunga Bella Pratiwi Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia 0000-0002-9304-5114
  • Ardian Rizal Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia 0000-0002-9104-5022
  • Valerinna Yogibuana Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia 0009-0001-0862-6273

bungabellap6@gmail.com

Keywords

Adult with congenital heart disease, atrial arrhythmia, patent ductus arteriosus closure, pulmonary hypertension

Abstract

Arrhythmias in adults with congenital heart disease (ACHD) can occur due to remodelling and post-intervention injury. As ablation is the gold standard for arrhythmia intervention, finding the electrical source from ACHD can be challenging, especially after surgical repair. We present an ACHD with patent ductus arteriosus (PDA) without risk factor cardiovascular disease, with post-closure complaints of frequent palpitations and a history of supraventricular tachycardia (SVT) after transcatheter PDA closure; electrocardiography (ECG) shows SVT. Mean pulmonary arterial pressure (MPAP) was 81 mmHg before PDA closure and 64 mmHg after closure. The patient was planned for 2D ablation, and concentric coronary sinus activation was found. VAV activation showed PPI-TCL >115 ms, ventriculoatrial interval <70 ms, SVT AVNRT/AVRT with excluded AT (V-A stimulus 202 ms). ECG and electrogram after radiofrequency ablation show successful ablation with paroxysmal atrial tachycardia. Detailed examination of ECG and echocardiography with manoeuvres is important to distinguish concomitant arrhythmia or correlation in ACHD.

View the entire article

Downloads

References

  1. Dellborg M, Giang KW, Eriksson P, Liden H, Fedchenko M, Ahnfelt A, et al. Adults with congenital heart disease: trends in event-free survival past middle age. Circulation 2023;147:930–938. doi: 10.1161/CIRCULATIONAHA.122.060834
  2. Arnaert S, De Meester P, Troost E, Droogne W, Van Aelst L, Van Cleemput J, et al. Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors. ESC Hear Fail 2021;8:2940–2950. doi: 10.1002/ehf2.13378
  3. Wasmer K, Eckardt L, Baumgartner H, Köbe J. Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease – narrative review. Cardiovasc Diagn Ther 2021;11:550–562. doi: 10.21037/cdt-20-634
  4. Ntiloudi D, Rammos S, Karakosta M, Kalesi A, Kasinos N, Giannakoulas G. Arrhythmias in patients with congenital heart disease: an ongoing morbidity. J Clin Med 2023;12:7020. doi: 10.3390/jcm12227020
  5. Chiriac A, Giardi D, Cheema KP, Espinosa S, Umadat G, Hodge DO, et al. Atrial arrhythmia predicts late events and mortality in patients with D-transposition of the great arteries and atrial switch repair. Int J Cardiol Congenit Heart Dis 2024;15:100491. doi: 10.1016/j.ijcchd.2023.100491
  6. Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc 2022;11:e025784. doi: 10.1161/JAHA.122.025784
  7. Huang Y, Chen Y, Su D, Qin S, Chen C, Liu D, et al. Follow-up of transcatheter closure of congenital heart disease complicated with pulmonary arterial hypertension in children. Front Pediatr 2025;13:1562782. doi: 10.3389/fped.2025.1562782
  8. Soulaidopoulos S, Brili S, Drakopoulou M, Sotiropoulos I, Archontakis S, Dilaveris P, et al. Catheter ablation in grown-up congenital heart disease patients: a single-center experience. Int J Cardiol Congenit Heart Dis 2022;7:100326. doi: 10.1016/j.ijcchd.2022.100326
  9. Jone PN, Ivy DD, Hauck A, Karamlou T, Truong U, Coleman RD, et al. Pulmonary hypertension in congenital heart disease: a scientific statement from the American Heart Association. Circ Heart Fail 2023;16:e00080. doi: 10.1161/HHF.0000000000000080
  10. Paul T, Krause U, Sanatani S, Etheridge SP. Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years. Europace 2023;25:euad155. doi: 10.1093/europace/euad155
  11. Rojas SF, Nattel S, Hiram R, Khairy P. Right ventricular electrophysiology and arrhythmias in adults with congenital heart disease: scientific basis for management. Can J Cardiol 2025;41:1081–1095. doi: 10.1016/j.cjca.2025.01.033
  12. Baroutidou A, Otountzidis N, Papazoglou AS, Moysidis DV, Kartas A, Mantziari L, et al. Atrial fibrillation ablation in congenital heart disease: therapeutic challenges and future perspectives. J Am Heart Assoc 2024;13:e032102. doi: 10.1161/JAHA.123.032102
  13. Francisco-Pascual J, Mallofré Vila N, Santos-Ortega A, Rivas-Gándara N. Tachyarrhythmias in congenital heart disease. Front Cardiovasc Med 2024;11:1395210. doi: 10.3389/fcvm.2024.1395210

Published

2025-09-24

Issue

Vol. 12 No. 10 (2025)

Categories

How to Cite

1.
Pratiwi BB, Rizal A, Yogibuana V. Supraventricular tachycardia in a young adult with congenital heart disease: successful ablation after patent ductus arteriosus closure. EJCRIM [Internet]. 2025 Sep. 24 [cited 2026 Nov. 3];12(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5699

Most read articles by the same author(s)